INFUSION COORDINATOR AND PATIENT CARE MANAGMENT at IMMUNOe Health & Research Centers - Centennial, Colorado, United States
At IMMUNOe, we have taken a unique approach to treating patients. Founded in 1994, we started as a single specialty practice.Today, we are focused on early intervention and treat a full spectrum of immune-related diseases and disorders- from Allergies, Asthma, Primary and Secondary Immune Deficiencies to Neuro-immune Diseases. By utilizing the knowledge and experience of our team of experts we are able to offer our patients unparalleled diagnostic therapy and prevention. In addition to our services at our health centers, IMMUNOe Research Centers is renowned for incorporating the latest therapies in its clinical research trials. We have built a reputation for excellence in clinical research. Our centers possess many attributes that have placed as one of the most trusted, and knowledgeable associates among leading pharmaceutical companies. Our qualified staff of project managers, principle investigators, clinical trial coordinators, regulatory specialists, pharmacists and quality control experts have successfully completed Phase I–IV clinical research trials in the United States, Latin America and Europe.With our focus on early diagnosis, specialized treatment and clinical research, IMMUNOe is a recognized leader in immune health. We strive to achieve and maintain the strongest and most balanced immune system possible for all of our patients. So rather than treat symptoms, we evaluate each trigger's role in inflammation, activation and regulation of your immune system.This whole system approach enables us to provide each IMMUNOe patient:- Highly individualized immune system evaluation- Early diagnosis and intervention- Understanding of the immune process- Integrated therapeutic approach- A personal philosophy of care.Our healthcare providers listen, engage and most of all, encourage active participation in your healthcare. Dr. Isaac Melamed has assembled a caring, dedicated staff that does just that.